Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ArriVent BioPharma, Inc. | 130,000 | reported | 02 Feb 2026 | tx 18+288,719−38,719 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | ArriVent BioPharma, Inc. | 130,000 | 0.00 USD | deriv |
| 11 Jul 2025 | EXERCISE | ArriVent BioPharma, Inc. | 2,050 | 2.28 USD | |
| 11 Jul 2025 | EXERCISE | ArriVent BioPharma, Inc. | 6,503 | 2.28 USD | |
| 11 Jul 2025 | EXERCISE | ArriVent BioPharma, Inc. | 2,600 | 2.28 USD | |
| 11 Jul 2025 | EXERCISE | ArriVent BioPharma, Inc. | 2,600 | 0.00 USD | deriv |
| 11 Jul 2025 | EXERCISE | ArriVent BioPharma, Inc. | 6,503 | 0.00 USD | deriv |
| 11 Jul 2025 | EXERCISE | ArriVent BioPharma, Inc. | 2,050 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | ArriVent BioPharma, Inc. | 120,000 | 0.00 USD | deriv |
| 19 Sept 2024 | EXERCISE | ArriVent BioPharma, Inc. | 2,471 | 2.28 USD | |
| 19 Sept 2024 | EXERCISE | ArriVent BioPharma, Inc. | 12,364 | 3.65 USD | |
| 19 Sept 2024 | EXERCISE | ArriVent BioPharma, Inc. | 7,164 | 2.28 USD | |
| 19 Sept 2024 | EXERCISE | ArriVent BioPharma, Inc. | 2,700 | 6.24 USD | |
| 19 Sept 2024 | EXERCISE | ArriVent BioPharma, Inc. | 2,867 | 2.28 USD | |
| 19 Sept 2024 | EXERCISE | ArriVent BioPharma, Inc. | 2,471 | 0.00 USD | deriv |
| 19 Sept 2024 | EXERCISE | ArriVent BioPharma, Inc. | 2,867 | 0.00 USD | deriv |
| 19 Sept 2024 | EXERCISE | ArriVent BioPharma, Inc. | 7,164 | 0.00 USD | deriv |
| 19 Sept 2024 | EXERCISE | ArriVent BioPharma, Inc. | 12,364 | 0.00 USD | deriv |
| 19 Sept 2024 | EXERCISE | ArriVent BioPharma, Inc. | 2,700 | 0.00 USD | deriv |